Propranolol in hypertension: a dose-response study. 1976

D B Galloway, and S C Glover, and W G Hendry, and A W Logie, and J C Petrie, and M C Smith, and J A Lewis, and W T Simpson

The effect of propranolol was studied in a double-blind crossover trial in 24 carefully selected hypertensive outpatients. Each patient received propranolol 60 mg/day, 120 mg/day, 240 mg/day, and placebo for four weeks each according to a randomised sequence. Propranolol 60 mg/day was no better than placebo in reducing blood pressure. The effects of propranolol 120 mg/day and 240 mg/day were not significantly different. Both doses reduced lying blood pressure by about 20/10 mm Hg from an initial level of 173/104 mm Hg. No difference was detected between the effects of the different doses of propranolol and placebo on weight or on the occurrence of adverse reactions.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011187 Posture The position or physical attitude of the body. Postures
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions

Related Publications

D B Galloway, and S C Glover, and W G Hendry, and A W Logie, and J C Petrie, and M C Smith, and J A Lewis, and W T Simpson
January 1979, Indian heart journal,
D B Galloway, and S C Glover, and W G Hendry, and A W Logie, and J C Petrie, and M C Smith, and J A Lewis, and W T Simpson
June 1973, Current therapeutic research, clinical and experimental,
D B Galloway, and S C Glover, and W G Hendry, and A W Logie, and J C Petrie, and M C Smith, and J A Lewis, and W T Simpson
January 1984, Indian heart journal,
D B Galloway, and S C Glover, and W G Hendry, and A W Logie, and J C Petrie, and M C Smith, and J A Lewis, and W T Simpson
May 1980, Clinical pharmacology and therapeutics,
D B Galloway, and S C Glover, and W G Hendry, and A W Logie, and J C Petrie, and M C Smith, and J A Lewis, and W T Simpson
March 1977, The Practitioner,
D B Galloway, and S C Glover, and W G Hendry, and A W Logie, and J C Petrie, and M C Smith, and J A Lewis, and W T Simpson
October 1976, The British journal of ophthalmology,
D B Galloway, and S C Glover, and W G Hendry, and A W Logie, and J C Petrie, and M C Smith, and J A Lewis, and W T Simpson
January 1984, Kardiologia polska,
D B Galloway, and S C Glover, and W G Hendry, and A W Logie, and J C Petrie, and M C Smith, and J A Lewis, and W T Simpson
January 1983, Therapie,
D B Galloway, and S C Glover, and W G Hendry, and A W Logie, and J C Petrie, and M C Smith, and J A Lewis, and W T Simpson
May 1992, Journal of hepatology,
D B Galloway, and S C Glover, and W G Hendry, and A W Logie, and J C Petrie, and M C Smith, and J A Lewis, and W T Simpson
January 1977, Proceedings of the Royal Society of Medicine,
Copied contents to your clipboard!